Periprosthetic Joint Infections

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Elute, Inc
Elute, IncUT - Salt Lake City
1 program
EP Granules with TobramycinN/A1 trial
Active Trials
NCT05361941RecruitingEst. Dec 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Elute, IncEP Granules with Tobramycin

Clinical Trials (1)

NCT05361941Elute, IncEP Granules with Tobramycin

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities

Start: Aug 2023Est. completion: Dec 2025
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space